Kaye Enterprises and Solon Ventures invest in Peakdale Molecular

Client(s) Kaye Enterprises Limited and Solon Ventures Limited

Jones Day represented Kaye Enterprises Limited and Solon Ventures Limited in connection with their purchase of Ordinary Shares and A Ordinary Shares in a private placement by Peakdale Molecular Limited, a provider of chemical products and services to pharmaceutical and biotechnology companies to accelerate drug discovery initiatives, in a second round investment.